Moderna Inc. said Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations. Together with Pfizer Inc’s vaccine, also shown to be more than 90% effective, and pending more safety data…… MORE